<p class="wp-block-paragraph"><a href="https://www.washingtonexaminer.com/tag/united-states" rel="noopener noreferrer" target="_blank">America</a> has recently addressed a significant issue related to addiction that does not involve traditional substances.</p>
<p class="wp-block-paragraph">Meta has agreed to pay up to $17.1 billion in a multistate settlement to resolve claims that features of Instagram and Facebook encouraged compulsive use among children and contributed to <a href="https://www.washingtonexaminer.com/tag/mental-health" rel="noopener noreferrer" target="_blank">mental health</a> issues. A separate agreement in <a href="https://www.washingtonexaminer.com/tag/texas" rel="noopener noreferrer" target="_blank">Texas</a> raises Meta’s total payout to approximately $18 billion. The company denies any wrongdoing. The settlement includes behavioral safeguards such as a two-hour daily limit for minors, restrictions during nighttime, and limits on notifications during school hours.</p>
<p class="wp-block-paragraph">This litigation highlights a broader issue in America regarding addiction-like behavior that does not involve intoxicating substances. It raises the question of whether addiction policy should focus more on the vulnerabilities of individuals rather than solely on the substances or behaviors themselves.</p>
<p class="wp-block-paragraph">Federal policy primarily addresses issues related to <a href="https://www.washingtonexaminer.com/tag/opioids" rel="noopener noreferrer" target="_blank">opioids</a>, alcohol, stimulants, nicotine, and gambling, which are not identical and do not necessarily require the same treatment approaches. However, they may engage similar brain systems related to reward, motivation, and self-control.</p>
<p class="wp-block-paragraph">The concept of Reward Deficiency Syndrome (RDS) offers a different perspective on addiction. It shifts the focus from what a person is addicted to, to understanding why they may be vulnerable to addiction in the first place.</p>
<p class="wp-block-paragraph">Research indicates that for some individuals, typical rewards may not provide sufficient reinforcement, leading them to seek stronger signals from drugs or highly stimulating behaviors. While genetics can play a role in this vulnerability, environmental factors, trauma, stress, mental health, and social conditions are also significant.</p>
<p class="wp-block-paragraph">RDS does not imply that dopamine is the sole factor in every addiction or that opioid-use disorder, alcoholism, gambling, and compulsive digital behavior are the same <a href="https://www.washingtonexaminer.com/tag/disease" rel="noopener noreferrer" target="_blank">disease</a>. Instead, it suggests that different addictive behaviors may be expressions of an underlying vulnerability in the brain's reward system.</p>
<p class="wp-block-paragraph">This perspective may clarify why stopping one addiction does not necessarily eliminate the risk of developing another. For instance, an individual may stop drinking but begin gambling, or someone recovering from drug use may develop another compulsive behavior. The specific target may change, but the underlying susceptibility may remain.</p>
<p class="wp-block-paragraph">Evidence-based medications and behavioral therapies are effective and should remain central to treatment. However, lasting recovery necessitates more than just removing someone from a specific substance; it requires helping them build a life where healthy activities can compete with pathological rewards.</p>
<p class="wp-block-paragraph">Current federal policy does not consistently reflect this reality. Funding, regulations, and success measures are often divided by substance, agency, and treatment setting. Opioids are treated separately from <a href="https://www.washingtonexaminer.com/tag/alcohol" rel="noopener noreferrer" target="_blank">alcohol</a>, and addiction treatment is frequently distinct from mental health care. Behavioral addictions are categorized differently, while the brain does not distinguish between these issues.</p>
<p class="wp-block-paragraph">A reward-centered approach would not eliminate drug-specific treatment, enforcement, regulation, or harm reduction. The goal is not to replace effective methods but to expand the objectives of addiction treatment.</p>
<p class="wp-block-paragraph">Federal addiction policy should not only ask, “Did this person stop using this substance?” but also, “Is this person recovering the ability to live without continually seeking an unhealthy source of reward?”</p>
<p class="wp-block-paragraph">This approach means integrating proven medications with behavioral and mental health care, physical activity, healthy sleep, stress management, family and social connections, and ongoing research into biologically informed treatments.</p>
<p class="wp-block-paragraph">The <a href="https://www.washingtonexaminer.com/tag/meta" rel="noopener noreferrer" target="_blank">Meta</a> settlement should be viewed as more than a response to social media issues. It serves as a reminder that compulsive reward-seeking can span substances, behaviors, and technologies while policies remain confined to specific categories.</p>
<p class="wp-block-paragraph">If the focus remains solely on what individuals are addicted to, the underlying reasons for their vulnerability to addiction may continue to be overlooked.</p>
<p class="wp-block-paragraph"><em>Kenneth Blum, PhD, is a neuroscientist and researcher in addiction biology. Kai-Uwe Lewandrowski, MD, PhD, is a spine surgeon and clinical researcher. Morgan P. Lorio, MD, FACS, is a retired spine surgeon and former president of the International Society for the Advancement of Spine Surgery.</em></p>